Störungen des Lipid- und Lipoproteinstoffwechsels
作者： Berthold Koletzko
DOI: 10.1007/978-3-642-41814-3_16
关键词:
摘要: Fur die Padiatrie klinisch wichtige Storungen des Lipidstoffwechsels umfassen Veranderungen der Plasmalipoproteine mit und ohne Hyperlipidamien, Lipidspeicherkrankheiten sowie Fettsaureoxidation.
springer.com
sci-hub.st 参考文章(34)
Koletzko B, Heine W, Haschke F, Ormission A, Lafeber H, Hernell O, Tormo R, Aggett Pj, Rey J, Committee report: childhood diet and prevention of coronary heart disease. ESPGAN Committee on Nutrition. European Society of Pediatric Gastroenterology and Nutrition. Journal of Pediatric Gastroenterology and Nutrition. ,vol. 19, pp. 261- ,(1994)
Albert Dirisamer, Nilouparak Hachemian, Robert Alexander Bucek, Florian Wolf, Markus Reiter, Kurt Widhalm, The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation European Journal of Pediatrics. ,vol. 162, pp. 421- 425 ,(2003) , 10.1007/S00431-003-1181-3
Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow up The Lancet. ,vol. 359, pp. 1379- 1387 ,(2002) , 10.1016/S0140-6736(02)08351-4
Richard B Colletti, Nancy K Roff, Ellis J Neufeld, Annette L Baker, Jane W Newburger, Timothy L McAuliffe, None, Niacin treatment of hypercholesterolemia in children. Pediatrics. ,vol. 92, pp. 78- 82 ,(1993)
Ågot L Amundsen, Leiv Ose, Marit S Nenseter, Fady Y Ntanios, Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. The American Journal of Clinical Nutrition. ,vol. 76, pp. 338- 344 ,(2002) , 10.1093/AJCN/76.2.338
Tatu A. Miettinen, Helena Gylling, Regulation of cholesterol metabolism by dietary plant sterols. Current Opinion in Lipidology. ,vol. 10, pp. 9- 14 ,(1999) , 10.1097/00041433-199902000-00003
Antonio M. Gotto, Jennifer E. Moon, Management of Cardiovascular Risk: The Importance of Meeting Lipid Targets The American Journal of Cardiology. ,vol. 110, pp. 3A- 14A ,(2012) , 10.1016/J.AMJCARD.2012.04.002
Martina C McGuinness, Heming Wei, Kirby D Smith, Therapeutic developments in peroxisome biogenesis disorders. Expert Opinion on Investigational Drugs. ,vol. 9, pp. 1985- 1992 ,(2000) , 10.1517/13543784.9.9.1985
Vasilios G. Athyros, Athanasios A. Papageorgiou, Athanasios G. Kontopoulos, Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia Atherosclerosis. ,vol. 163, pp. 205- 206 ,(2002) , 10.1016/S0021-9150(02)00005-9
Raphael Schiffmann, Jeffrey B. Kopp, Howard A. Austin III, Sharda Sabnis, David F. Moore, Thais Weibel, James E. Balow, Roscoe O. Brady, Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. ,vol. 285, pp. 2743- 2749 ,(2001) , 10.1001/JAMA.285.21.2743